Main competitors
Dividend Yield (Y) Dividend Yield (Y+1) P/E (Y) Price to Book (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Capi.($)
-.--%-.--%20.6x1.7x2.9x14.42x14.02x 10.49B
0.5%0.53%17.95x2.36x4.83x12.27x14.67x 75.21B
-.--%-.--%58.66x7.89x15.52x33.29x41.68x 61.16B
0.53%0.55%44.56x4.73x7.05x23.06x30.99x 58.53B
2.63%2.86%22.43x2.8x4.09x11.88x13.71x 56.54B
-.--%-.--%15.84x1.31x2.63x8.29x9.16x 24.12B
-.--%-.--%17.13x3.62x3.39x10.17x10.32x 20.85B
-.--%0.02%81.94x7.95x9.81x88.44x101.48x 19.91B
-.--%-.--%-5.19x1.92x5.92x-3.49x-3.29x 16.34B
-.--%-.--%-22.28x-7.19x32.03x-32.72x-31.76x 14.7B
-.--%-.--%-656.06x2.81x4.37x11.29x23.01x 12.38B
-.--%-.--%-16.19x - 582.69x-15.96x-16.12x 10.93B
-.--%-.--%-46.99x201.64x13.93x-58.14x-51.72x 8.94B
3%1.94%6.06x2.52x2.75x4.12x4.16x 8.48B
-.--%-.--%42.47x - 19.93x46.08x47.83x 8.27B
-.--%-.--%-249.34x - - - - 8.18B
1.5%1.81%17.24x1.17x2.05x8.49x11.3x 7.63B
Average 0.48% 0.45% -38.30x 16.80x 44.62x 10.09x 13.71x 24.86B
Weighted average by Cap. 0.6% 0.63% 1.81x 8.02x 23.24x 16.15x 20.48x
Biopharmaceuticals